Amoéba Secures Emergency Authorization in Italy for Biofungicide

Amoéba, a greentech firm from France, has received a 120-day emergency authorization in Italy for its biofungicide AXPERA to combat basil downy mildew. This pathogen significantly affects basil, a key Italian crop, with up to 80% of plants impacted under favorable conditions. The authorization addresses a critical need for solutions in a market where options are decreasing, especially for organic farmers who comprise a significant portion of the market.

This move is strategic for Italy's basil sector, which plays a significant role in the European market, particularly for Genovese basil used in pesto. Pesto alla Genovese's market has seen robust growth, underscoring the importance of protecting basil crops to maintain economic stability.

The authorization, supported by Italian grower associations and the Ministry of Health, allows the preventive use of AXPERA. It aligns with Amoéba's European strategy to deploy biocontrol solutions against fungal diseases pending full marketing approval.